GoodRx Holdings Inc. (NASDAQ:GDRX) is one of the oversold stocks to buy now. On January 5, Bank of America analyst Allen Lutz ...

Drug discount app GoodRx is expanding into health content to provide answers to the most Googled questions about personal health. The company launched GoodRx Health as an online health resource that ...

Cheap prescription-drugs platform GoodRx is getting into the content business. The company is debuting GoodRx Health, a website that answers the most Googled questions about personal health. The move ...

Key Insights Significant control over GoodRx Holdings by individual investors implies that the general public has ...

On Thursday, GoodRx (GDRX) launched a new way to pay for and get prescriptions filled that mimics the e-commerce experience. The company will eventually build it out for all its pharmacy partners. The ...

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), America’s digital resource for healthcare, today launched GoodRx Health to provide research-based answers to vital health questions.

Sanofi's Lantus, its most commonly prescribed insulin, will sell for $35 a month through GoodRx Holdings Inc. in a deal that signals the drug-discount site's growing business with large pharma ...

Like other successful and innovative companies, GoodRx has adapted and evolved to stay relevant, viable, and true to its mission. Improving healthcare and patient outcomes requires that stakeholders ...

Surescripts Introduces New Patient Experience Solution to Transform the Medication Experience and Improve Patient Access, Affordability and AdherenceARLINGTON, Va. & SANTA MONICA, Calif.--(BUSINESS ...

Sanofi’s Lantus, its most commonly prescribed insulin, will sell for $35 a month through GoodRx Holdings Inc. in a deal that signals the drug-discount site’s growing business with large pharma ...